ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1990

Corticosteroid Use in Idiopathic Aortitis: A Systematic Review

Nancy Maltez1 and Nataliya Milman2, 1Internal Medicine, University of Ottawa, Ottawa, ON, Canada, 2Division of Rheumatology, University of Ottawa, Ottawa, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: corticosteroids, large vessel vasculitis, outcomes and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Idiopathic aortitis (IA) is a poorly defined entity with no specific pathological or clinical criteria for its classification or diagnosis, except for the presence of aortic inflammation and absence of clinical features of another systemic condition. Most of the present knowledge about IA comes from retrospective series of cases with pathologically identified aortitis. The objective of this systematic review was to clarify available data regarding outcomes in patients treated with corticosteroids and those without treatment.

Methods:

Data sources: Search strategy using terms “aortitis” and “idiopathic/isolated” identified published articles and abstracts using MEDLINE and EMBASE databases.

Study selection: Inclusion criteria required that cases of idiopathic aortitis be confirmed by pathology. Abstracts and case reports were excluded except for abstracts that complemented published manuscripts; reviews were used for triangulation. Authors were contacted for clarifications when required.

Data extraction: Data were extracted independently by two reviewers. Our primary goal was to compare outcomes between patients treated with corticosteroids and untreated patients. The primary outcomes included: development of new vascular lesions, clinical complications, delayed diagnosis of other rheumatological diseases and vascular death. Secondary outcomes included preoperative symptoms, ESR/CRP levels and presence of branch vessel disease.

Results:

Search yielded 262 records of which 10 fulfilled inclusion criteria. The majority of studies were retrospective. Even the few studies that reported on treatment status described very few events of interest: Miller et al described no new vascular lesions in two treated patients versus one lesion in 19 untreated patients while Clifford et al reported 2 new vascular lesions in 11 treated and 27 in 54 untreated patients. Wang et al reported one new vascular lesion (new aortic aneurysm) in the treated group and none in the untreated patients. Two studies described the need for re-operation, reported in two treated and none of the untreated patients in each of the studies. Finally, Liang et al reported 4 deaths (of unspecified cause) among untreated patients and none in the treated group.

Conclusion:

Few studies report clinical outcomes in patients diagnosed with idiopathic aortitis treated with corticosteroids. Consequently, there exists a lack of data to guide therapy and long term management of these individuals. The retrospective nature and small cohorts from which data is extracted make it difficult to draw conclusions. Future studies are required to better understand outcomes.


Disclosure: N. Maltez, None; N. Milman, None.

To cite this abstract in AMA style:

Maltez N, Milman N. Corticosteroid Use in Idiopathic Aortitis: A Systematic Review [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/corticosteroid-use-in-idiopathic-aortitis-a-systematic-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/corticosteroid-use-in-idiopathic-aortitis-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology